12. “Epidiolex is the result of extensive pre-clinical research of CBD in epilepsy which dates back to 2007 and which has reported significant anti-epileptiform and anticonvulsant activity using a variety of in vitro and in vivo models.”
http://dev-gwpharma.pantheonsite.io/about-us/history-approach
Copyright: luaeva / 123RF Stock Photo
